Prevalence of COVID-19 and seroprevalence to SARS-CoV-2 in a rheumatologic patient population from a tertiary referral clinic in Israel.

Tali EviatarOfir ElaloufVictoria FurerYael Goldstein-LahatYael ParanSara PelSharon NevoMichael ZisapelYifat AlcalayOri Elkayam

Published in: Internal medicine journal (2021)

The prevalence of COVID-19 in a population of rheumatologic patients was similar to that of the general population. Mild/asymptomatic cases may be prevalent according to serologic tests. The major risk factor for infection is exposure to a known case of COVID-19, and immunosuppression did not play a role in the risk of infection.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
end stage renal disease
risk factors
primary care
newly diagnosed
ejection fraction
chronic kidney disease
case report
patient reported outcomes